Form 4: ADC Therapeutics Director Ron Squarer Disposes of Shares for Tax Obligations

Sentiment:

Insider Transaction Report


ADC Therapeutics SA Director Ron Squarer disposed of 15,184 common shares on June 13, 2025, to cover tax withholding obligations related to restricted share unit vesting.

Summary

  • Ron Squarer, a Director of ADC Therapeutics SA (ADCT), reported a transaction on June 13, 2025.
  • The transaction involved the disposition of 15,184 common shares.
  • The shares were disposed of at a price of $3.58 per share.
  • This disposition was made to satisfy tax withholding obligations in connection with the vesting of previously granted restricted share units.
  • Following this transaction, Mr. Squarer beneficially owns 93,627 common shares directly.

Sentiment

Score: 5

Explanation: The transaction is a routine disposition of shares to cover tax obligations upon RSU vesting, which is a neutral event. It does not indicate a lack of confidence or a strategic sale.

Future Outlook

NA

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction and does not provide information relevant to broader industry trends or competitors. It reflects a standard tax-related share disposition for a director of a biotechnology company.

Comparison to Industry Standards

  • This document is a standard SEC Form 4 filing, reporting an insider transaction. It does not contain information that allows for comparison to industry-specific financial or operational benchmarks, nor does it mention comparable companies or projects.
  • The transaction itself, a disposition of shares to cover tax obligations upon RSU vesting, is a common occurrence across all industries for executives and directors receiving equity compensation.

Stakeholder Impact

  • Shareholders: A minor reduction in direct insider ownership, but for a routine tax purpose, so minimal impact on investor sentiment.
  • Employees: No direct impact on employees mentioned.

Key Dates

DateDescription
06/13/2025Date of transaction (disposition of common shares)
06/17/2025Date Form 4 was signed/filed

Recommendation

hold

Keywords

ADC Therapeutics, ADCT, Ron Squarer, Form 4, SEC filing, insider transaction, share disposition, restricted share units, tax withholding

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.